- Home
- AIRG vs ALGS Comparison
AIRG vs ALGS Comparison
Compare AIRG & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIRG
- ALGS
- Stock Information
- Founded
- AIRG 1995
- ALGS 2018
- Country
- AIRG United States
- ALGS United States
- Employees
- AIRG N/A
- ALGS N/A
- Industry
- AIRG Radio And Television Broadcasting And Communications Equipment
- ALGS Biotechnology: Pharmaceutical Preparations
- Sector
- AIRG Technology
- ALGS Health Care
- Exchange
- AIRG Nasdaq
- ALGS Nasdaq
- Market Cap
- AIRG 51.7M
- ALGS 53.0M
- IPO Year
- AIRG 2016
- ALGS 2020
- Fundamental
- Price
- AIRG $4.17
- ALGS $9.86
- Analyst Decision
- AIRG Strong Buy
- ALGS Strong Buy
- Analyst Count
- AIRG 3
- ALGS 2
- Target Price
- AIRG $8.50
- ALGS $60.00
- AVG Volume (30 Days)
- AIRG 39.9K
- ALGS 72.0K
- Earning Date
- AIRG 11-11-2025
- ALGS 11-05-2025
- Dividend Yield
- AIRG N/A
- ALGS N/A
- EPS Growth
- AIRG N/A
- ALGS N/A
- EPS
- AIRG N/A
- ALGS N/A
- Revenue
- AIRG $56,820,000.00
- ALGS $3,174,000.00
- Revenue This Year
- AIRG N/A
- ALGS N/A
- Revenue Next Year
- AIRG $21.58
- ALGS N/A
- P/E Ratio
- AIRG N/A
- ALGS N/A
- Revenue Growth
- AIRG 6.84
- ALGS N/A
- 52 Week Low
- AIRG $3.17
- ALGS $3.76
- 52 Week High
- AIRG $10.34
- ALGS $46.80
- Technical
- Relative Strength Index (RSI)
- AIRG 45.42
- ALGS 50.65
- Support Level
- AIRG $4.10
- ALGS $9.60
- Resistance Level
- AIRG $4.35
- ALGS $10.70
- Average True Range (ATR)
- AIRG 0.16
- ALGS 0.76
- MACD
- AIRG 0.00
- ALGS -0.02
- Stochastic Oscillator
- AIRG 29.26
- ALGS 41.30
About AIRG Airgain Inc.
Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.